Trial Profile
Expanded access program (Hospital Exemption Program) of DCVax-L in patients with brain cancers
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 24 Jun 2015
Price :
$35
*
At a glance
- Drugs Dendritic cell vaccine-Northwest Biotherapeutics (Primary)
- Indications Glioma
- Focus Adverse reactions; Therapeutic Use
- 24 Jun 2015 New trial record